• Recruiting

NCT03657251: MMRF CureCloud Research Initiative

Updated: May 23


NCT03657251: MMRF CureCloud Research Initiative

MMRF CureCloud Research Initiative

NDMM

RRMM

MGUS/SMM


MMRF CureCloud Research Initiative

Observational Study


The MMRF CureCloud Research Initiative, a Direct-to-Patient Research effort aimed at enrolling 5,000 individuals from whom comprehensive molecular and immune analyses will be generated from blood specimens and the resulting data aggregated with the correlating clinical information. Blood will be collected from all participants after electronic online consenting via a mailed blood kit designed for a mobile phlebotomy appointment. Through the consenting process, participants will also be authorizing linkage to their electronic medical records information.


Sponsor:Multiple Myeloma Research Foundation

Genetic: liquid biopsy

 

ClinicalTrials.gov Identifier: NCT03657251


Official Title: The MMRF CureCloud Multiple Myeloma Research Initiative

First Posted : September 5, 2018


Click here for details on ClinicalTrials.gov

 

Patients that have been diagnosed with Multiple Myeloma, or one of its precursor conditions to share their clinical information and blood samples to help scientists and researchers understand these conditions better.


The study will use submitted blood samples to perform comprehensive research that will include, among others, genomic and immune characterization, as well as collect past and present medical records to combine and compare with the blood sample analysis.


Learn more: https://mmrfcurecloud.org/

 

What is the MMRF CureCloud®?

Welcome to the MMRF CureCloud!

Multiple Myeloma Research Foundation



NCT01454297: MMRF CoMMpass Study in Newly Diagnosed Multiple Myeloma - (CoMMpass)

NCT01454297: MMRF CoMMpass Study in Newly Diagnosed Multiple Myeloma - (CoMMpass)

 

United States, Massachusetts

- Massachusetts: Dana-Farber Cancer Institute/Harvard Cancer Center Boston

 


Posts Archive